407 related articles for article (PubMed ID: 31501275)
1. Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.
Demma MJ; Mapelli C; Sun A; Bodea S; Ruprecht B; Javaid S; Wiswell D; Muise E; Chen S; Zelina J; Orvieto F; Santoprete A; Altezza S; Tucci F; Escandon E; Hall B; Ray K; Walji A; O'Neil J
Mol Cell Biol; 2019 Nov; 39(22):. PubMed ID: 31501275
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Myc transcriptional activity by a mini-protein based upon Mxd1.
Demma MJ; Hohn MJ; Sun A; Mapelli C; Hall B; Walji A; O'Neil J
FEBS Lett; 2020 May; 594(10):1467-1476. PubMed ID: 32053209
[TBL] [Abstract][Full Text] [Related]
3. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
4. The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.
Savino M; Annibali D; Carucci N; Favuzzi E; Cole MD; Evan GI; Soucek L; Nasi S
PLoS One; 2011; 6(7):e22284. PubMed ID: 21811581
[TBL] [Abstract][Full Text] [Related]
5. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
[TBL] [Abstract][Full Text] [Related]
6. The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.
Montagne M; Beaudoin N; Fortin D; Lavoie CL; Klinck R; Lavigne P
PLoS One; 2012; 7(2):e32172. PubMed ID: 22384171
[TBL] [Abstract][Full Text] [Related]
7. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
Wahlström T; Belikov S; Arsenian Henriksson M
Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
[TBL] [Abstract][Full Text] [Related]
8. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
[TBL] [Abstract][Full Text] [Related]
9. OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors.
Jung LA; Gebhardt A; Koelmel W; Ade CP; Walz S; Kuper J; von Eyss B; Letschert S; Redel C; d'Artista L; Biankin A; Zender L; Sauer M; Wolf E; Evan G; Kisker C; Eilers M
Oncogene; 2017 Apr; 36(14):1911-1924. PubMed ID: 27748763
[TBL] [Abstract][Full Text] [Related]
10. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.
Beaulieu ME; Jauset T; Massó-Vallés D; Martínez-Martín S; Rahl P; Maltais L; Zacarias-Fluck MF; Casacuberta-Serra S; Serrano Del Pozo E; Fiore C; Foradada L; Cano VC; Sánchez-Hervás M; Guenther M; Romero Sanz E; Oteo M; Tremblay C; Martín G; Letourneau D; Montagne M; Morcillo Alonso MÁ; Whitfield JR; Lavigne P; Soucek L
Sci Transl Med; 2019 Mar; 11(484):. PubMed ID: 30894502
[TBL] [Abstract][Full Text] [Related]
12. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
Si J; Yu X; Zhang Y; DeWille JW
Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
[TBL] [Abstract][Full Text] [Related]
13. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
Vervoorts J; Lüscher B
Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
[TBL] [Abstract][Full Text] [Related]
14. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
15. Computational insights into the differentiated binding affinities of Myc, Max, and Omomyc dimers to the E-boxes of DNA.
Dai Y; Zhang J; Wang Y; Liu L; Gao J
J Mol Model; 2022 Sep; 28(10):329. PubMed ID: 36149511
[TBL] [Abstract][Full Text] [Related]
16. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
Hann SR; Dixit M; Sears RC; Sealy L
Genes Dev; 1994 Oct; 8(20):2441-52. PubMed ID: 7958908
[TBL] [Abstract][Full Text] [Related]
17. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site.
Swanson HI; Yang JH
Nucleic Acids Res; 1999 Aug; 27(15):3205-12. PubMed ID: 10454619
[TBL] [Abstract][Full Text] [Related]
18. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
Nair SK; Burley SK
Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of compound NSC13728 as Omomyc homodimer stabilizer by molecular dynamics simulation and MM/GBSA free energy calculation.
Gao J; Wang Y; Li K; Zhang J; Geng X
J Mol Model; 2022 Mar; 28(4):92. PubMed ID: 35294626
[TBL] [Abstract][Full Text] [Related]
20. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
